Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter T Soboslay

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Plos Neglected Tropical Diseases|March 2, 2018
Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectinKossi Komlan, Patrick S Vossberg, Richard G Gantin, et al.
Plos One|June 3, 2014
Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort studyMéba Banla, Solim Tchalim, Potochoziou K Karabou, et al.
Plos Neglected Tropical Diseases|February 2, 2022
Echinococcus multilocularis specific antibody, systemic cytokine, and chemokine levels, as well as antigen-specific cellular responses in patients with progressive, stable, and cured alveolar echinococcosis: A 10-year follow-upBeate Grüner, Lynn Peters, Andreas Hillenbrand, et al.
Wiener Klinische Wochenschrift|April 9, 2010
Applied field research for comprehensive helminth infection controlPeter T Soboslay, Richard G Gantin, Méba Banla, et al.
Microbes and Infection|December 29, 2011
Chemokines and cytokines in patients with an occult Onchocerca volvulus infectionChristian J Lechner, Richard G Gantin, Tanja Seeger, et al.
Plos Neglected Tropical Diseases|May 3, 2022
Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central TogoSaskia I Johanns, Richard G Gantin, Bawoubadi Wangala, et al.
Parasites & Vectors|June 15, 2016
Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasisAllison Golden, Dunia Faulx, Michael Kalnoky, et al.
Plos Neglected Tropical Diseases|January 9, 2016
A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulusAllison Golden, Eric J Stevens, Lindsay Yokobe, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Plos Neglected Tropical Diseases|March 2, 2018
Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectinKossi Komlan, Patrick S Vossberg, Richard G Gantin, et al.
Plos One|June 3, 2014
Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort studyMéba Banla, Solim Tchalim, Potochoziou K Karabou, et al.
Plos Neglected Tropical Diseases|February 2, 2022
Echinococcus multilocularis specific antibody, systemic cytokine, and chemokine levels, as well as antigen-specific cellular responses in patients with progressive, stable, and cured alveolar echinococcosis: A 10-year follow-upBeate Grüner, Lynn Peters, Andreas Hillenbrand, et al.
Wiener Klinische Wochenschrift|April 9, 2010
Applied field research for comprehensive helminth infection controlPeter T Soboslay, Richard G Gantin, Méba Banla, et al.
Microbes and Infection|December 29, 2011
Chemokines and cytokines in patients with an occult Onchocerca volvulus infectionChristian J Lechner, Richard G Gantin, Tanja Seeger, et al.
Plos Neglected Tropical Diseases|May 3, 2022
Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central TogoSaskia I Johanns, Richard G Gantin, Bawoubadi Wangala, et al.
Parasites & Vectors|June 15, 2016
Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasisAllison Golden, Dunia Faulx, Michael Kalnoky, et al.
Plos Neglected Tropical Diseases|January 9, 2016
A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulusAllison Golden, Eric J Stevens, Lindsay Yokobe, et al.
Pageof 3